Liu et al. showed that the diabetes typically found in patients with pancreatic cancer is characterized by profound peripheral insulin resistance, which impairs skeletal muscle glycogen synthesis and storage, and is also associated with a post-insulin resistance defect and no difference in SLC2A4 gene expression [24]. This evidence concerns the gene SLC2A4 and familial pancreatic carcinoma.